Home  Feedback  Career  Sitemap  Contact Us
 
Market Buzz
Corporate Info
Market Analysis
Movers
Corporate Action
Other Markets
IPO
 
Panyam Cement ( 11-Dec-18 )
Panyam Cements & Mineral Industries announced that the 62th Annual General Meeting (AGM) of the company will be held on 31 December 2018.
Reliance Inds. ( 11-Dec-18 )
Reliance Industries has allotted 25,000 Partly-paid Unsecured Redeemable Non-Convertible Debentures of face value of Rs.10,00,000 each aggregating to Rs.2,500 crore (PPD Series lA Debentures); and 30,000 Unsecured Redeemable Non-Convertible _Debentures of face value of Rs.10,00,000 each aggregating to Rs.3,000 crore (PPD Series IB Debentures) on private placement basis.
Shree Cement ( 11-Dec-18 )
Shree Cement has received reaffirmation in credit ratings from CARE for the bank facilities of the company as mentioned below -

Long term bank facilities (Rs 1100 crore) - CARE AAA; Stable (Reaffirmed)
Short term bank facilities (Rs 800 crore) - CARE A1+ (Reaffirmed)

Unichem Labs. ( 11-Dec-18 )
Unichem Laboratories has received tentative approval for its ANDA, Tadalafil Tablets, 2.5 mg, 5 mg, 10 mg and 20 mg from the USFDA for a generic version of Eli Lilly's Cialis, 2.5 mg, 5 mg, 10 mg and 20 mg.
VBC Ferro Alloys ( 11-Dec-18 )
VBC Ferro Alloys announced that Vuppala Srinivas Rao, Director of the company has resigned on 10 December 2018.
Warren Tea ( 11-Dec-18 )
Warren Tea announced that ICRA has revised the long term rating of the Company from [ICRA]BBB+ to [ICRA]BBB and the short term rating from [ICRA]A2 to [ICRA]A3+.
Wipro ( 11-Dec-18 )
Wipro announced that that it has taken over the strategic design consulting team at Syfte, an Australian design agency which uses human-centred design thinking to solve compelling client challenges. Syfte's team of designers will be absorbed within Designit, Wipro's strategic design arm, further strengthening its design and innovation capabilities, expanding its reach in Australia and Asia Pacific and enhancing the transformation services offered by Wipro Digital.

Increasingly, global enterprise clients in Australia recognise that strategic design is a critical part of any digital or business transformation. By adding Syfte's skills and expertise to Designit, Wipro will be better positioned to support its clients' digital agenda.

Wipro Digital and Designit serve clients from 18 digital pods around the world.

Dr Reddy's Labs ( 11-Dec-18 )
Dr Reddys Laboratories announced the launch of Omeprazole Delayed-Release Tablets, 20 mg, an over-the-counter (OTC) store-brand equivalent of Prilosec® OTC (omeprazole delayed-release) Tablets, 20 mg, in the United States market as approved by the U.S. Food and Drug Administration (USFDA).

OTC Omeprazole Delayed-Release Tablets, 20 mg, is a proton pump inhibitor used to treat frequent heartburn occurring two or more days per week in adults.

The combined market of Prilosec OTC® and private label omeprazole OTC products had U.S. retail sales of approximately $492 million for the most recent twelve months ending in October 2018 according to IRI.

Dr. Reddy's Omeprazole Delayed-Release Tablets, 20 mg, is available in 14 count bottles sold in cartons of 1, 2, or 3 bottles each. Each bottle contains one complete 14-day course of treatment.

Back Top
Source:Capital Market

Member Code : NCDEX - 00241 | MCX - 31435
SEBI Regn. Nos : BSE INB010643030 | NSE(EQ) INB230643037 | NSE(FUT) INF230643037 FOR INVESTORS GRIEVANCE : complaints@cilsecurities.com
FOR DP GRIEVANCE : grievance@cilsecurities.com
Privacy Policy  |  Disclaimer | BrokerNorms |  BSE Complaints
Useful Links :  NSE | BSE  | CDSL | MCX  | NCDEX | SEBI | RBI
Designed , Developed & Powered By C-MOTS Infotech
(ISO 9001:2015 certified)